Sarah Jessica Parker said “goodbye” to Mylan, the manufacturer of EpiPen, after they announced that they will be raising prices to more than $500.
The new price is 400% higher than it was when they started selling the product in 2007. Back then the epinephrine shot retailed at $57 bucks.
“I’m left disappointed, saddened and deeply concerned by Mylan’s actions,” the Sex and the City actress wrote on Instagram. “I do not condone this decision and I have ended my relationship with Mylan as a direct result of it.”
Parker’s son James Wilkie requires an EpiPen for his peanut allergy.
“I hope they will seriously consider the outpouring of voices of those millions of people who are dependent on the device, and take swift action to lower the cost to be more affordable for whom it is a life-saving necessity,” Parker continued.
Parker is not only arguing against the price hike for her son but for all the millions of people who are being affected and literally cannot afford to dish out that much money for something that was once affordable.
Mylan has since announced they will be taking serious actions to fix the situation.
In a statement they said they will eliminate out-of-pocket expenses for uninsured and under-insured patients and covering up to $300 of out-of-pocket costs at pharmacies.
They also said they will “open a pathway to provide [EpiPens] directly to patients.”